Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions

Journal of Virology

Volumn 71, Issue 9, 1997, Pages 7110-7113

  Dorfman, Tatyana ^a   Weimann, Andreas ^a   Borsetti, Alessandra ^a   Walsh, Christopher T ^a   Göttlinger, Heinrich G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; MUTANT PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRION; VIRUS INFECTIVITY;

EID: 0030760256     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.9.7110-7113.1997     Document Type: Article

References (39)

1. Aberham, C., S. Weher, and W. Phares. 1996. Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporins. J. Virol. 70:3536-3544.
2. Bartz, S. R., E. Hohenwalter, M.-K. Hu, D. H. Rich, and M. Malkovsky. 1995. Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A. Proc. Natl. Acad. Sci. USA 92:5381- 5385.
3. Billich, A., F. Hammerschmid, P. Peichl, R. Wenger, G. Zenke, V. Quesniaux, and B. Rosenwirth. 1995. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactions. J. Virol. 69:2451-2461.
4. Braaten, D., C. Aberham, E. K. Franke, L. Yin, W. Phares, and J. Luban. 1996. Cyclosporin A-resistant human immunodeficiency virus type 1 mutants demonstrate that gag encodes the functional target of cyclophilin A. J. Virol. 70:5170-5176.
5. Braaten, D., H. Ansari, and J. Luban. 1997. The Hydrophobic pocket of cyclophilin is the binding site for the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 71:2107-2113.
6. Braaten, D., E. K. Franke, and J. Luban. 1996. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J. Virol. 70:3551-3560.
7. Bram, R. J., D. T. Hung, P. K. Martin, S. L. Schreiber, and G. R. Crabtree. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760-4769.
8. Bukovsky, A. A., T. Dorfman, A. Weimann, and H. G. Göttlinger. 1997. Net association with human immunodeficiency virus type 1 virions and cleavage by the viral protease. J. Virol. 71:1013-1018.
9. Colgan, J., H. E. H. Yuan, E. K. Franke, and J. Luban. 1996. Binding of the human immunodeficiency virus type 1 Gag polyprolein to cyclophilin A is mediated by the central region of capsid and requires Gag dimerization. J. Virol. 70:4199-4310.
10. Dorfman, T., and H. G. Göttlinger. 1996. The human immunodeficiency virus type 1 capsid p2 domain confers sensitivity to the cyclophilin-binding drug SDZ NIM 811. J. Virol. 70:5751-5757.
11. Dorfman, T., F. Mammano, W. A. Haseltine, and H. G. Göttlinger. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J. Virol. 68:1689-1696.
12. Fischer, G., B. Wittmann-Liebold, K. Lang, T. Kiefhaber, and F. X. Schmid. 1989. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337:476-478.
13. Franke, E. K., and J. Luban. 1996. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the Gag-cyclophilin A interaction. Virology 222:279-282.
14. Franke, E. K., H. E. H. Yuan, and J. Luban. 1994. Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372:359-362.
15. Gamble, T. R., F. F. Vajdos, S. Yoo, D. K. Worthylake, M. Houseweart, W. I. Sundquist, and C. P. Hill. 1996. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-I capsid. Cell 87:1285-1294.
16. Gitti, R. K., B. M. Lee, J. Walker, M. F. Summers, S. Yoo, and W. I. Sundquist. 1996. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science 273:231-235.
17. Handschumacher, R., M. Harding, J. Rice, and R. Drugge. 1984. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226:544-547.
18. Hunter, E. 1994. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin. Virol. 5:71-83.
19. Kallen, J., C. Spitzfaden, M. G. M. Zurini, G. Wider, H. Widmer, K. Wüthrich, and M. D. Walkinshaw. 1991. Structure of human cyclophilin and its binding site for cyclosporin A determined by X-ray crystallography and NMR spectroscopy. Nalure 353:276-274.
20. Kallen, J., and M. D. Walkinshaw. 1992. The X-ray structure of a tetrapeptide bound to the active site of human cyclophilin A. FEBS Lett. 300:286-290.
21. Ke, H., D. Mayrose, P. J. Belshaw, D. G. Alberg, S. L. Schreiber, Z. Y. Chang, F. A. Etzkorn, S. Ho, and C. T. Walsh. 1994. Crystal structures of cyclophilin A complexed with cyclosporin A and N-methyl-4-[(E)-2-butenyl]-4,4-dimethylthreonine cyclosporin A. Structure 2:33-44.
22. Ke, H., L. D. Zydowsky, J. Liu, and C. T. Walsh. 1991. Crystal structure of recombinant human T-cell cyclophilin A at 2.5 Å resolution. Proc. Natl. Acad. Sci. USA 88:9483-9487.
23. Kraulis, P. J. 1991. MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J. Appl. Cryst. 24:946-950.
24. Liu, J., C.-M. Chen, and C. T. Walsh. 1991 Human and Escherichia coli cyclophilins: sensitivity to inhibition by the immunosuppressant cyclosporin A correlates with a specific tryptophan residue. Biochemistry 30:2306-2310.
25. Luban, J., K. L. Bossolt, E. K. Franke, G. V. Kalpana, and S. P. Goff. 1993. Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73:1067-1078.
26. Momany, C., L. C. Kovari, A. J. Prongay, W. Keller, R. K. Gitti, B. M. Lee, A. E. Gorbalenya, L. Tong, J. McClure, L. S. Ehrlich, M. F. Summers, C. Carter, and M. G. Rossmann. 1996. Crystal structure of dimeric HIV-1 capsid protein. Nat. Struct. Biol. 3:763-770.
27. Ott, D. E., L. V. Coren, D. G. Johnson, R. C. Sowder, L. O. Arthur, and L. E. Henderson. 1995. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain. AIDS Res. Hum. Retroviruses 11:1003-1006.
28. Pflügl, G., J. Kallen, T. Schirmer, J. N. Jansonius, M. G. M. Zurini, and M. D. Walkinshaw. 1993. X-ray structure of a decameric cyclophilin-cyclo- sporin crystal complex. Nature 361:91-94.
29. Price, E. R., L. D. Zydowsky, M. Jin, C. H. Baker, F. D. McKeon, and C. T. Walsh. 1991. Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence. Proc. Natl. Acad. Sci. USA 88:1903-1907.
30. Rosenwirth, B., A. Billich, R. Datema, P. Donatsch, F. Hammerschmid, R. Harrison, P. Hiestand, H. Jaksche, P. Mayer, P. Peichl, V. Quesniaux, F. Schatz, H.-J. Schuurman, R. Traber, R. Wenger, B. Wolff, G. Zenke, and M. Zurini. 1994. Inhibition of human immunodeficiency virus replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine A analog. Antimicrob. Agents Chemother. 38:1763-1772.
31. Schreiber, S. L. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251:283-287.
32. Takahashi, N., T. Hayano, and M. Suzuki. 1989. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-hinding protein cyclophilin. Nature 337:473-475.
33. Takebe, Y., M. Seiki, J.-I. Fujisawa, P. Hoy, K. Yokota, K.-I. Arai, M. Yoshida, and N. Arai. 1988. SRα promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 41 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8:460-472.
34. Thali, M., A. Bukovsky, E. Kondo, B. Kosenwirth, C. Walsh, J. Sodroski, and H. G. Göttlinger. 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372:363-365.
35. Thériault, Y., T. M. Logan, R. Meadows, L. Yu, E. T. Olejniczak, T. F. Holzman, R. L. Simmer, and S. W. Fesik. 1993. Solution structure of the cyclosporin A/cyclophilin complex by NMR. Nature 361:88-91.
36. Walsh, C. T., L. D. Zydowsky, and F. D. McKeon. 1992. Cyclosporin A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transaction. J. Biol. Chem. 267:13115-13118.
37. Zhao, Y., Y. Chen, M. Schutkowski, G. Fischer, and H. Ke. 1997. Cyclophilin A complexed with a fragment of HIV-1 gag protein: insights into HIV-1 infectious activity. Structure 5:139-146.
38. Zhao, Y., and H. Ke. 1996. Crystal structure implies that cyclophilin predominantly catalyzes the trans to cis isomerization. Biochemistry 35:7356-7361.
39. Zydowski, L. D., F. A. Etzkorn, H. Y. Chang, S. B. Ferguson, L. A. Stolz, S. I. Ho, and C. T. Walsh. 1992. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and caleineurin inhibition. Protein Sci. 1:1092-1099.